[Apathy and Dementia]

Kazunori Okada1, Shuhei Yamaguchi

  • 1Oda Silverclinic.

Insights

Apathy significantly impacts neuropsychiatric patients and their caregivers, affecting quality of life and recovery. This review explores interventions for apathy in mild cognitive impairment (MCI) and dementia.

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Apathy is a common symptom in neuropsychiatric disorders, impacting patient well-being and rehabilitation.
  • It significantly affects the quality of life for patients and their caregivers.
  • Apathy is a key early sign in the progression from mild cognitive impairment (MCI) to dementia.

Purpose of the Study:

  • To review the neurobiological underpinnings of apathy.
  • To examine the prevalence of apathy in MCI and dementia.
  • To assess interventions for apathy in these populations.

Main Methods:

  • Literature review of neurobiological basis.
  • Analysis of prevalence data.
  • Evaluation of non-pharmacologic and pharmacologic interventions.

Main Results:

  • Apathy is a widespread issue in neuropsychiatric conditions.
  • It negatively influences patient outcomes and daily living.
  • Interventions for apathy in MCI and dementia require further investigation.

Conclusions:

  • Understanding the neurobiology of apathy is crucial.
  • Effective management strategies are needed for MCI and dementia patients.
  • Further research into interventions can improve patient care and prognosis.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
660
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
918
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
964